BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Center for Health-System Improvement (CHI) "Works-in-Progress S
 eminar"Tuesday February 13\, 2024\,&nbsp\;12:00 - 1:00 PMHybrid Attendance
 : 4.108 JSA Conference Room or ZoomPresenter:&nbsp\;Dr. Sadaf Arefi Milani
 \, PhD\, MPH&ldquo\;Dementia Medications and their Association with Pain M
 edication Use in Medicare Beneficiaries with Dementia and Chronic Pain&rdq
 uo\;Abstract:Chronic pain is highly prevalent among older adults with Alzh
 eimer&rsquo\;s disease and related dementias (ADRD). Memantine and acetylc
 holinesterase inhibitors (ACHEI\; donepezil\, rivastigmine\, and galantami
 ne)\, approved for the\n    treatment of dementia symptoms\, may also have
  analgesic properties. However\, findings on the clinical utility of these
  dementia medications for the treatment of chronic pain are mixed.Bio:Sada
 f Milani\, PhD\, MPH is an Assistant Professor in the Department of Epidem
 iology. Dr. Milani received a Master of Public Health and PhD in Epidemiol
 ogy from the University of Florida. She also completed an NIA T32 postdoct
 oral fellowship\n    on health of older minorities at the UTMB Sealy Cente
 r on Aging. Dr. Milani studies sex/gender differences in life course pathw
 ays for cognitive decline\, dementia\, and Alzheimer&rsquo\;s disease. Her
  recent work is focused on pain and pain medication\n    as potentially mo
 difiable risk factors for cognitive decline and dementia. She is a Fellow 
 of the Sealy Center on Aging and the Center for Interdisciplinary Research
  on Women&rsquo\;s Health.
DTEND:20240213T190000Z
DTSTAMP:20260614T165056Z
DTSTART:20240213T180000Z
LOCATION:
SEQUENCE:0
SUMMARY:CHI Seminar - Sadaf Arefi Milani\, PhD\, MPH
UID:RFCALITEM639170346565306981
X-ALT-DESC;FMTTYPE=text/html:<h2 style="text-align:center\;">Center for Hea
 lth-System Improvement (CHI) "Works-in-Progress Seminar"</h2><p style="tex
 t-align:center\;"><strong>Tuesday February 13\, 2024\,&nbsp\;12:00 - 1:00 
 PM</strong><br /><strong><span class="red">Hybrid Attendance: 4.108 JSA Co
 nference Room or Zoom</span></strong><br /><strong>Presenter:&nbsp\;Dr. Sa
 daf Arefi Milani\, PhD\, MPH</strong></p><p style="text-align:center\;font
 -size:large\;"><img src="https://www.utmb.edu/images/centerofhealthsystems
 improvementchilibraries/chi-speakers/feb-2024/sadaf-arefi-milani-phd-mph.j
 pg?sfvrsn=1cb77356_7&amp\;sf_site_temp=true&amp\;sf_site=00000000-0000-000
 0-0000-000000000000" title="Sadaf Arefi Milanin\, PhD\, MPH" alt="Sadaf Ar
 efi Milanin\, PhD\, MPH" sf-size="16472" /></p><h3 style="text-align:cente
 r\;">&ldquo\;Dementia Medications and their Association with Pain Medicati
 on Use in Medicare Beneficiaries with Dementia and Chronic Pain&rdquo\;</h
 3><p style="text-align:left\;"><strong>Abstract:</strong>Chronic pain is h
 ighly prevalent among older adults with Alzheimer&rsquo\;s disease and rel
 ated dementias (ADRD). Memantine and acetylcholinesterase inhibitors (ACHE
 I\; donepezil\, rivastigmine\, and galantamine)\, approved for the\n    tr
 eatment of dementia symptoms\, may also have analgesic properties. However
 \, findings on the clinical utility of these dementia medications for the 
 treatment of chronic pain are mixed.</p><hr style="text-align:center\;" />
 <div class="video-embed "><iframe src="https://utmb.hosted.panopto.com/Pan
 opto/Pages/Embed.aspx?id=e704e04a-7e57-467e-8609-b115014dc803&amp\;autopla
 y=false&amp\;offerviewer=true&amp\;showtitle=true&amp\;showbrand=true&amp\
 ;captions=false&amp\;interactivity=all" height="405" width="720" style="bo
 rder:1px solid #464646\;" allow="autoplay" aria-label="Panopto Embedded Vi
 deo Player"></iframe></div><hr style="text-align:center\;" /><p><strong>Bi
 o:</strong>Sadaf Milani\, PhD\, MPH is an Assistant Professor in the Depar
 tment of Epidemiology. Dr. Milani received a Master of Public Health and P
 hD in Epidemiology from the University of Florida. She also completed an N
 IA T32 postdoctoral fellowship\n    on health of older minorities at the U
 TMB Sealy Center on Aging. Dr. Milani studies sex/gender differences in li
 fe course pathways for cognitive decline\, dementia\, and Alzheimer&rsquo\
 ;s disease. Her recent work is focused on pain and pain medication\n    as
  potentially modifiable risk factors for cognitive decline and dementia. S
 he is a Fellow of the Sealy Center on Aging and the Center for Interdiscip
 linary Research on Women&rsquo\;s Health.</p>
END:VEVENT
END:VCALENDAR